NL193245C - Aan 1Ó,25-dihydroxyvitamine D2 verwante verbinding en farmaceutisch preparaat met een het calciummetabolisme regulerende werking dat een dergelijke verbinding bevat. - Google Patents

Aan 1Ó,25-dihydroxyvitamine D2 verwante verbinding en farmaceutisch preparaat met een het calciummetabolisme regulerende werking dat een dergelijke verbinding bevat. Download PDF

Info

Publication number
NL193245C
NL193245C NL8420137A NL8420137A NL193245C NL 193245 C NL193245 C NL 193245C NL 8420137 A NL8420137 A NL 8420137A NL 8420137 A NL8420137 A NL 8420137A NL 193245 C NL193245 C NL 193245C
Authority
NL
Netherlands
Prior art keywords
compound
dihydroxyvitamin
formula
compounds
calcium
Prior art date
Application number
NL8420137A
Other languages
English (en)
Dutch (nl)
Other versions
NL8420137A (nl
NL193245B (nl
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of NL8420137A publication Critical patent/NL8420137A/nl
Publication of NL193245B publication Critical patent/NL193245B/xx
Application granted granted Critical
Publication of NL193245C publication Critical patent/NL193245C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
NL8420137A 1983-05-09 1984-05-09 Aan 1Ó,25-dihydroxyvitamine D2 verwante verbinding en farmaceutisch preparaat met een het calciummetabolisme regulerende werking dat een dergelijke verbinding bevat. NL193245C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49286383A 1983-05-09 1983-05-09
US49286383 1983-05-09
US60732784A 1984-05-04 1984-05-04
US60732784 1984-05-04

Publications (3)

Publication Number Publication Date
NL8420137A NL8420137A (nl) 1985-04-01
NL193245B NL193245B (nl) 1998-12-01
NL193245C true NL193245C (nl) 1999-04-02

Family

ID=27050897

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8420137A NL193245C (nl) 1983-05-09 1984-05-09 Aan 1Ó,25-dihydroxyvitamine D2 verwante verbinding en farmaceutisch preparaat met een het calciummetabolisme regulerende werking dat een dergelijke verbinding bevat.

Country Status (7)

Country Link
JP (3) JPH02288873A (da)
AU (1) AU568549B2 (da)
CH (1) CH665834A5 (da)
DE (4) DE3490215T (da)
DK (3) DK171397B1 (da)
NL (1) NL193245C (da)
WO (1) WO1984004527A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8520265A (nl) * 1984-10-04 1986-09-01 Wisconsin Alumni Res Found Derivaten van vitamine d en werkwijzen voor het bereiden daarvan.
KR910004337B1 (ko) * 1985-01-17 1991-06-26 위스콘신 알럼니 리서치 화운데이션 비타민 d 유도체 및 이를 함유하는 약제
CA1341408C (en) * 1988-08-02 2002-12-10 Charles W. Bishop Method for treating and preventing loss of bone mass
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
US4973584A (en) * 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives
JP2645130B2 (ja) * 1989-03-31 1997-08-25 日清製粉株式会社 ステロイド誘導体
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
IN171426B (da) * 1990-02-14 1992-10-10 Wisconsin Alumni Res Found
NZ254424A (en) * 1992-06-22 1997-09-22 Lunar Corp Pharmaceutical composition and use of 1 alpha hydroxy-pre-vitamin d
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
KR20000071039A (ko) 1997-02-13 2000-11-25 비숍 찰스 더블유. 비타민 ｄ 화합물의 표적화된 치료학적 전달
ES2759874T3 (es) 2008-03-12 2020-05-12 Opko Ireland Global Holdings Ltd 1,25-Dihidroxivitamina D2 estabilizada y método de preparación de la misma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260549A (en) * 1979-05-21 1981-04-07 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4267117A (en) * 1978-06-19 1981-05-12 The Upjohn Company Compounds and process
US4269777A (en) * 1979-05-21 1981-05-26 Wisconsin Alumni Research Foundation Isotopically labeled vitamin D derivatives and processes for preparing same

Also Published As

Publication number Publication date
DE3490215T (de) 1985-05-15
CH665834A5 (de) 1988-06-15
JPH0651624B2 (ja) 1994-07-06
JPH02288829A (ja) 1990-11-28
NL8420137A (nl) 1985-04-01
DK8685A (da) 1985-01-08
DE3448360C2 (da) 1991-10-02
DK171397B1 (da) 1996-10-14
DK184588D0 (da) 1988-04-06
DK183291D0 (da) 1991-11-07
JPH0339505B2 (da) 1991-06-14
JPH02288854A (ja) 1990-11-28
AU568549B2 (en) 1988-01-07
DE3448412C2 (da) 1991-12-12
JPH0610188B2 (ja) 1994-02-09
DK172567B1 (da) 1999-01-18
WO1984004527A1 (en) 1984-11-22
JPH02288873A (ja) 1990-11-28
DK172733B1 (da) 1999-06-21
DK8685D0 (da) 1985-01-08
NL193245B (nl) 1998-12-01
DE3490215C2 (da) 1991-07-25
DK184588A (da) 1988-04-06
DK183291A (da) 1991-11-07
AU3011584A (en) 1984-12-04

Similar Documents

Publication Publication Date Title
US4588716A (en) Method for treating metabolic bone disease in mammals
NL193245C (nl) Aan 1Ó,25-dihydroxyvitamine D2 verwante verbinding en farmaceutisch preparaat met een het calciummetabolisme regulerende werking dat een dergelijke verbinding bevat.
US5552392A (en) Method of treating hypoparathyroidism with (20S) vitamin D compounds
EP1305030B1 (en) Use of 2-alpha-methyl-19-nor-20(s)-1-alpha,25-dihydroxyvitamin d3 in bone replacement
EP1482951B1 (en) Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses
US5194431A (en) 24-cyclopropane vitamin D derivatives
AU2001273303A1 (en) Use of 2alpha-methyl-19-nor-20(s)-1alpha,25-dihydroxyvitamin D3 to increase bone strength
NL8220265A (nl) 26,26,26,27,27,27,-hexafluor-1alfa,25-dihydroxycholecalciferol alsmede werkwijze voor de bereiding daarvan.
JPH02504154A (ja) 細胞分化の誘発に有効な化合物の製法
US5373004A (en) 26,28-methylene-1α, 25-dihydroxyvitamin D2 compounds
EP1021401A1 (en) Calcitriol derivatives and their uses
IE50815B1 (en) 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
NL8420327A (nl) Isomeren van hydroxyvitamine d2.
JPS60501261A (ja) １α，２５―ジヒドロキシル化ビタミンＤ↓２化合物及びその製造方法
US5552393A (en) Method of treating metabolic bone diseases with 21-norvitamin D compounds
US5036061A (en) Process for the preparation of 1 alpha,25-dihydroxylated vitamin D2 and related compounds
DE3590021C2 (de) 1alpha-Hydroxyvitamin D-Derivat und dieses enthaltendes Arzneimittel
NL8120067A (en) 25-Hydroxy-26,26,26,27,27,27,27-hexa:fluoro-cholecalciferol - useful as vitamin D3, like agent for calcium deficiency diseases

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 20031201